A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

M Cornberg, HA Razavi, A Alberti… - Liver …, 2011 - Wiley Online Library
Abstract Background and Aim: Decisions on public health issues are dependent on reliable
epidemiological data. A comprehensive review of the literature was used to gather country …

Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention

L Wiessing, M Ferri, B Grady, M Kantzanou, I Sperle… - PloS one, 2014 - journals.plos.org
Background People who inject drugs (PWID) are a key population affected by hepatitis C
virus (HCV). Treatment options are improving and may enhance prevention; however …

Viral hepatitis and HIV coinfection

MS Sulkowski - Journal of hepatology, 2008 - Elsevier
Persons at high risk for human immunodeficiency virus (HIV) infection are also likely to be at
risk for other infectious pathogens, including hepatitis B virus (HBV) or hepatitis C virus …

Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place

H Hagan, ER Pouget, DC Des Jarlais… - American journal of …, 2008 - academic.oup.com
The authors examined the relation between time since onset of illicit drug injection (time at
risk) and rates of hepatitis C virus (HCV) infection by using meta-regression. In 72 …

Survival of hepatitis C virus in syringes: implication for transmission among injection drug users

E Paintsil, H He, C Peters… - The Journal of …, 2010 - academic.oup.com
Background. We hypothesized that the high prevalence of hepatitis C virus (HCV) among
injection drug users might be due to prolonged virus survival in contaminated syringes …

Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001

DC Des Jarlais, T Perlis, K Arasteh, LV Torian… - Aids, 2005 - journals.lww.com
Objective: To assess trends in HIV, hepatitis C virus (HCV) and HIV/HCV infection among
injecting drug users (IDU) from 1990 to 2001 in New York City. The 1990–2001 time period …

Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013

E Ruppé, L Armand-Lefèvre, C Estellat… - …, 2014 - eurosurveillance.org
Healthy travellers to countries where carbapenemases-producing Enterobacteriaceae
(CPE) are endemic might be at risk for their acquisition, even without contact with the local …

Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users

CHSB van den Berg, C Smit, M Bakker… - European journal of …, 2007 - Springer
Injecting drug users (DU) are at high risk for hepatitis C virus (HCV) and HIV infections. To
examine the prevalence and incidence of these infections over a 20-year period (1985 …

Current status, historical highlights, and basic principles of harm reduction.

SE Collins, SL Clifasefi, DE Logan, LS Samples… - 2012 - psycnet.apa.org
In this book, we seek to explore and embrace the diversity of harm reduction instead of trying
to simplify its definition or constrain its reach. In this chapter, we define and examine harm …

Clinical course of hepatitis C virus during the first decade of infection: cohort study

HE Harris, ME Ramsay, N Andrews, KP Eldridge - Bmj, 2002 - bmj.com
Objective: To determine the clinical course of hepatitis C virus in the first decade of infection
in a group of patients who acquired their infections on a known date. Design: Cohort study …